Australia Sales of Travelan ® increased 90% to AUD $1.851 million during December 2024 Quarter compared to AUD $1.007 million ...

Following the successful launch of its GLP Compass (™), Digbi Health continues to innovate by expanding its obesity test capabilities in 2025. These enhancements guide care providers and benefit ...

When applying the treatment policy estimand 2, people treated with semaglutide 7.2 mg achieved a superior weight loss of 18.7% compared to a reduction of 15.6% with semaglutide 2.4 mg and 3.9% with ...

Legend Memory Care brings award-winning, results-oriented expert care, which has been shown to improve cognition, memory function and socialization. “We're very proud to expand the Legend mission to ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to ...

Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin ...

Enthea is proud to announce that it will be presenting at the upcoming Sequire Investor Summit 2025. The 2025 Edition of the Sequire Investor Summit is scheduled for January 21st-23rd, 2025, at ...

The collaboration between Magellan and Laguna Treatment Center focuses on how well the provider treats patients with the goal to drive meaningful and objectively measurable outcomes. With a ...

The Super Air Smart ICU is available now in the United States and will be on display at the 2025 Veterinary Meeting & Expo (VMX), Booth 913, Jan. 25 – 29 in Orlando, FL. For more information, visit ...

Henri de Romrée joined the business as Chief Strategy Officer in November 2023. He was appointed Deputy CEO in March 2024, focused on developing growth opportunities in the Other Accelerators business ...

“We are pleased to have Abacus Analytics achieve the HFMA Peer Reviewed designation,” said HFMA Senior Vice President Professional Practice Richard L. Gundling, FHFMA, CMA. “The review process is ...

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...